GSK regulatory submission for myelofibrosis medicine momelotinib accepted for review by Japanese regulator Ruchika Sharma12 Sept 2023 11:29 AM ISTLondon: GSK plc has announced that the Ministry of Health, Labour and Welfare (MHLW), Japan, has accepted for review a new drug application (NDA) for...
GSK regulatory submission accepted for review by Japanese regulator for Nucala use in adults with chronic rhinosinusitis with nasal polyps Ruchika Sharma3 Sept 2023 12:45 PM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted for review a supplementary new drug...
Pfizer sued by GSK for patent infringement over RSV vaccine Ruchika Sharma3 Aug 2023 12:30 PM ISTA GSK spokesperson said in a statement that intellectual property protections are the "foundation of research-based companies' ability to drive...
GSK gets USFDA nod for Jemperli plus chemotherapy for dMMR/MSI-H primary advanced or recurrent endometrial cancer Ruchika Sharma1 Aug 2023 11:30 AM ISTJemperli is already approved in the US as monotherapy in adult patients with dMMR recurrent or advanced endometrial cancer that has progressed on or...
GlaxoSmithKline Pharma posts 11 percent rise in Q4 profit Ruchika Sharma28 July 2023 12:30 PM ISTBengaluru: GlaxoSmithKline Pharmaceuticals, the Indian unit of UK's GSK plc, posted an 11% rise in first-quarter profit on Wednesday, buoyed by strong...
Compugen wins on PVRIG European patent opposition pursued by GSK, a third party Ruchika Sharma18 July 2023 2:39 PM ISTHolon: Compugen Ltd., a clinical-stage cancer immunotherapy company has announced that the broad claims of Compugen's Anti-PVRIG Antibodies...
GSK RSV shot Arexvy approved in Britain for adults aged 60 years and older Ruchika Sharma10 July 2023 3:30 PM ISTBritain: Britain's health regulator approved GSK's vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and...
GSK concludes acquisition of BELLUS Health Ruchika Sharma29 Jun 2023 1:30 PM ISTUpon completion of the Arrangement, GSK acquired all outstanding common shares of BELLUS for US$14.75 per common share in cash, representing a total...
USFDA grants fast track designation for GSK Neisseria gonorrhoeae investigational vaccine Ruchika Sharma27 Jun 2023 1:30 PM ISTGonorrhoea is a sexually transmitted infection caused by a bacterium called Neisseria gonorrhoeae.
Japan approves GSK shingles vaccine Shingrix for at risk adults aged 18 and over Ruchika Sharma27 Jun 2023 12:30 PM ISTLondon: GSK plc has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved an updated indication for Shingrix...
GSK reaches settlement in US Zantac litigation Ruchika Sharma23 Jun 2023 1:30 PM ISTUnited States: GSK Plc on Friday said it reached a confidential settlement of a litigation in the United States over claims that the British...
USFDA extends review period of GSK Momelotinib by three months Ruchika Sharma17 Jun 2023 10:00 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (FDA) has extended the review period of the new drug application (NDA) for...
